November 2025
1. VARGHESE P, Garcia-Cuellar MP, Slany RK
   The myeloid transcription factor Elf1 regulates genes with function in innate immunity.
   Exp Hematol. 2025;151:104864.
   

   >> Share

   
   October 2025
2. CONNEELY SE, Quezada A, Kurtz KJ, Zhang N, et al
   Cohesin haploinsufficiency is tolerated in Cbfb::MYH11-driven murine acute myeloid leukemia.
   Exp Hematol. 2025 Oct 29:105287. doi: 10.1016/j.exphem.2025.105287.
   

   >> Share

   
   September 2025
3. ERNST P, Kyei P, Yokoyama A
   KMT2A-rearranged leukemia: from mechanism to drug development.
   Exp Hematol. 2025 Sep 6:105247. doi: 10.1016/j.exphem.2025.105247.
   

   >> Share

   
   
4. SANGHA G, Huntly BJP
   Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis.
   Exp Hematol. 2025;149:104821.
   

   >> Share

   
   
5. YOSHIDA S, Onozawa M, Yokoyama S, Matsukawa T, et al
   Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks.
   Exp Hematol. 2025;149:104819.
   

   >> Share

   
   August 2025
6. WANG J, Xu L, Wang G, Wu W, et al
   ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming.
   Exp Hematol. 2025 Aug 6:104862. doi: 10.1016/j.exphem.2025.104862.
   

   >> Share

   
   
7. SAMAREH B, Klimenkova O, Aghaallaei N, Cheng L, et al
   NAMPT-mediated deacetylation of HCLS1 protein promotes clonogenic growth of pediatric CML cells.
   Exp Hematol. 2025;148:104801.
   

   >> Share

   
   July 2025
8. FOSSELTEDER J, Brauchart T, Schlacher A, Sconocchia T, et al
   Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells.
   Exp Hematol. 2025;147:104790.
   

   >> Share

   
   June 2025
9. ZHANG A, Qiu S
   Advances of RARalpha fusion genes in acute promyelocytic leukemia.
   Exp Hematol. 2025 Jun 7:104822. doi: 10.1016/j.exphem.2025.104822.
   

   >> Share

   
   May 2025
10. LU J, Xue X, Wang H, Hao Y, et al
    Notch1 activation and inhibition in T cell acute lymphoblastic leukemia subtypes.
    Exp Hematol. 2025 May 8:104771. doi: 10.1016/j.exphem.2025.104771.
    

    >> Share

    
    
11. CISA-WIECZOREK S, Hernandez-Alvarez MI, Parreno M, Munoz JP, et al
    D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1.
    Exp Hematol. 2025;145:104748.
    

    >> Share

    
    April 2025
12. FOURNIER M, Dubuissez M, Neault M, Delisle JS, et al
    Unbiased analysis of NUP98-KDM5A-induced murine leukemia reveals phenotypic heterogeneity recapitulating human disease subtypes.
    Exp Hematol. 2025 Apr 19:104791. doi: 10.1016/j.exphem.2025.104791.
    

    >> Share

    
    March 2025
13. GUL AZ, Selek S, Bekiroglu S, Demirel M, et al
    Serum NMR metabolomics in distinct subtypes of hematologic malignancies.
    Exp Hematol. 2025;143:104710.
    

    >> Share

    
    
14. SARCHI M, Doulatov S
    Understanding Human Oncogene Function and Cooperativity in Myeloid Malignancy Using iPSCs.
    Exp Hematol. 2025;143:104697.
    

    >> Share

    
    
15. GUIRGUIS AA
    RNA methylation: where to from here for hematologic malignancies?
    Exp Hematol. 2025;143:104694.
    

    >> Share

    
    February 2025
16. TACHIBANA T, Izumi A, Arai S, Takeda T, et al
    Preconditioning intervention before allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
    Exp Hematol. 2025 Feb 12:104746. doi: 10.1016/j.exphem.2025.104746.
    

    >> Share

    
    
17. DE GROOT AP, Nguyen H, Pouw JS, Weersing E, et al
    CBX7 inhibitors affect H3K9 methyltransferase-regulated gene repression in leukemic cells.
    Exp Hematol. 2025;142:104691.
    

    >> Share

    
    January 2025
18. AMOR AR, Enlund S, Sinha I, Jiang Q, et al
    A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44 Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic Leukemia Cells.
    Exp Hematol. 2025 Jan 8:104712. doi: 10.1016/j.exphem.2025.104712.
    

    >> Share

    
    November 2024
19. QU Y, Shourabizadeh H, Subramanian A, Aleman DM, et al
    DIFFERENTIAL IMPACT OF CD34+ CELL DOSE FOR DIFFERENT AGE GROUPS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE LEUKEMIA: A MACHINE LEARNING-BASED DISCOVERY.
    Exp Hematol. 2024 Nov 22:104684. doi: 10.1016/j.exphem.2024.104684.
    

    >> Share

    
    October 2024
20. KOHNKE T, Feng Y, Majeti R
    A New Era of Functional Experimentation in Human Hematopoiesis and Leukemia Research.
    Exp Hematol. 2024 Oct 1:104652. doi: 10.1016/j.exphem.2024.104652.
    

    >> Share

    
    September 2024
21. KHAMARI R, Degand C, Fovez Q, Trinh A, et al
    Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors.
    Exp Hematol. 2024;137:104253.
    

    >> Share

    
    August 2024
22. CAMIOLO G, Mullen CG, Ottersbach K
    Mechanistic insights into the developmental origin of pediatric hematologic disorders.
    Exp Hematol. 2024;136:104583.
    

    >> Share

    
    June 2024
23. ONG KOK, Mok MMH, Niibori-Nambu A, Du L, et al
    Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.
    Exp Hematol. 2024 Jun 12:104255. doi: 10.1016/j.exphem.2024.104255.
    

    >> Share

    
    
24. STRAUBE J, Janardhanan Y, Haldar R, Bywater MJ, et al
    Immune control in acute myeloid leukemia.
    Exp Hematol. 2024 Jun 12:104256. doi: 10.1016/j.exphem.2024.104256.
    

    >> Share

    
    
25. ROGERS JH, Rosen A, Reyes JM, Ketkar S, et al
    Dose-dependent effects of Dnmt3a in an inducible murine model of Kras(G12D)-driven leukemia.
    Exp Hematol. 2024 Jun 2:104248. doi: 10.1016/j.exphem.2024.104248.
    

    >> Share

    
    
26. XU JJ, Viny AD
    Chromatin organization in myelodysplastic syndrome.
    Exp Hematol. 2024;134:104216.
    

    >> Share

    
    May 2024
27. ZHOU Q, Li Z, Xi Y
    EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment.
    Exp Hematol. 2024;133:104175.
    

    >> Share

    
    March 2024
28. PANTING RG, Kotecha RS, Cheung LC
    The critical role of the bone marrow stromal microenvironment for development of drug screening platforms in leukemia.
    Exp Hematol. 2024 Mar 27:104212. doi: 10.1016/j.exphem.2024.104212.
    

    >> Share

    
    
29. GOSWAMI M, Bose PD
    Gut Microbial Dysbiosis in the Pathogenesis of Leukemia: An Immune-based Perspective.
    Exp Hematol. 2024 Mar 23:104211. doi: 10.1016/j.exphem.2024.104211.
    

    >> Share

    
    
30. LIU Q, Zhai Y, Hui Y, Chen J, et al
    Identification of Red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
    Exp Hematol. 2024 Mar 18:104206. doi: 10.1016/j.exphem.2024.104206.
    

    >> Share

    
    February 2024
31. TANAKA T, Kudo K, Kanezaki R, Yuzawa K, et al
    Anti-leukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome.
    Exp Hematol. 2024 Feb 9:104179. doi: 10.1016/j.exphem.2024.104179.
    

    >> Share

    
    
32. RANDALL J, Evans K, Watts B, Kosasih HJ, et al
    IN VIVO ACTIVITY OF THE SECOND-GENERATION PROTEASOME INHIBITOR IXAZOMIB AGAINST PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA XENOGRAFTS.
    Exp Hematol. 2024 Feb 4:104176. doi: 10.1016/j.exphem.2024.104176.
    

    >> Share

    
    
33. MERZ AMA, Platzbecker U
    Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasms.
    Exp Hematol. 2024;130:104130.
    

    >> Share

    
    December 2023
34. ALQAZZAZ MA, Luciani GM, Vu V, Machado RM, et al
    Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations.
    Exp Hematol. 2023 Dec 8:S0301-472X(23)01773-3. doi: 10.1016/j.exphem.2023.
    

    >> Share

    
    
35. BUROCZIOVA M, Grusanovic S, Vanickova K, Kosanovic S, et al
    Chronic inflammation promotes cancer progression as a second hit.
    Exp Hematol. 2023;128:30-37.
    

    >> Share

    
    October 2023
36. XIE Y, Tan L, Wu K, Li D, et al
    MiR-455-3p mediates PPARalpha through UBN2 to promote apoptosis and autophagy in acute myeloid leukemia cells.
    Exp Hematol. 2023 Oct 5:S0301-472X(23)01734-4. doi: 10.1016/j.exphem.2023.
    

    >> Share

    
    September 2023
37. GUARNERA L, Santinelli E, Galossi E, Cristiano A, et al
    Microenvironment in Acute Myeloid Leukemia: focus on senescence mechanisms, therapeutic interactions and future directions.
    Exp Hematol. 2023 Sep 21:S0301-472X(23)01705.
    

    >> Share

    
    
38. HAN L, Wu J, Lyu X, Yu J, et al
    Genetic Mutation Signature for Relapse Prediction in Normal Karyotype Acute Myeloid Leukemia.
    Exp Hematol. 2023 Sep 20:S0301-472X(23)01706.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share